Reply to "Discussion: Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study"

Molecular Hydrogen as a Medical Gas for the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Possible Efficacy Based on a Literature Review

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disorder that is characterized by fatigue that persists for more than 6 months, weakness, sleep disturbances, and cognitive dysfunction. There are multiple possible etiologies for ME/CFS, among which mitochondrial dysfunction plays a major role in abnormal energy metabolism. The potential of many substances for the treatment of ME/CFS has been examined; however, satisfactory outcomes have not yet been achieved. The development of new substances for curative, not symptomatic, treatments is desired. Molecular hydrogen (H₂) ameliorates mitochondrial dysfunction by scavenging hydroxyl radicals, the most potent oxidant among reactive oxygen species. Animal experiments and clinical trials reported that H₂ exerted ameliorative effects on acute and chronic fatigue. Therefore, we conducted a literature review on the mechanism by which H₂ improves acute and chronic fatigue in animals and healthy people and showed that the attenuation of mitochondrial dysfunction by H₂ may be involved in the ameliorative effects. Although further clinical trials are needed to determine the efficacy and mechanism of H₂ gas in ME/CFS, our literature review suggested that H₂ gas may be an effective medical gas for the treatment of ME/CFS.